Guys,
For a forum of Valuepickr quality, we should not even be discussing Lycos Internet.
You don't need to read Financial Shenanigans to find issues with the stock.
Their con-call pdfs (not voice recordings) has the following as people who participated.
Mr. Vinayak Angadi from Christ University
Mr. Kuberan Marimuthu. He is an Individual Investor.
Mr. Sankar Rao. He is an Individual Investor. etc.
Guys, wake up and smell the coffee.Regards
Sriram
Hi Guys,
does the q2 results of shalimar paints inspire any confidence? What do you guys think about the current valuations of the company?
can u tell me those rules,i even dnt know that
those rules are listed on BSE and its the same for last many years, so those rules are not really a problem i think. The issue is the upside cap that they have imposed. What it means is that no matter what, you cannot have more than 400% gains in a year from a stock. how sad.
what are rules regarding change of circuit from 20% to 10% and then to 5% and vice versa.i mean for example- a stock after successive 20% circuit moves to 10% circuit then again after 10% uc it moves to 5% ,after that afterhow many days its 5% circuit will change to 20%
@j2eeprofession_
I agree to your points.
Its more like BSE is indirectly encouraging trading on the exchange. Silly rule.
Whats the analyst views on latest acquisition by TAKE? EBIDTA margins quite low at 10-12%.what cud be the value add by TAKE which may result in margin improvement?
This presentation probably gives a good overview of the Clinical Data Management work at a high level.
https://globalhealthtrials.tghn.org/site_media/media/articles/QAWhat_is_clinical_data_management.pdf
that's because trigyn is listed on both NSE and BSE and this rule applies to "BSE only" listed companies. Clearly this is a very stupid thing to do and i hope this move encourages companies to list on NSE as well ... also just like you have started calculating the maximum possible gains that can come in a stock, a lot of others would start doing it and this will only encourage trading. In my opinion we should all call at the numbers listed on that BSE notice and sound our displeasure to them.
Congnizant healthcare practice seems to be big, contributing almost 1/3rd of their revenue.
Trying to study more about their abilities in clinical data management and drug safety field which would be a more like to like comparison with take sol.
Healthnet was acquired by Centene and not congnizant http://marketrealist.com/2015/07/centene-announces-acquisition-health-net/
On Trizettto
Congnizant's press release says http://news.cognizant.com/2014-11-20-Cognizant-Completes-Acquisition-of-TriZetto-Creating-a-Fully-Integrated-Healthcare-Technology-and-Operations-Leader
"TriZetto software manages the health benefits of close to half the insured population of the U.S. and supports about a quarter of all U.S. care providers. The company is now a part of Cognizant's healthcare practice whose clients include 16 of the top 20 U.S. health plans, and four of the top five pharmacy benefit management companies."
So this seems a different kind of work than what Take does.